The following are some of the healthcare sector stocks that moved up in after-hours trading on Monday.
Cyclacel Pharmaceuticals Inc. (CYCC) has determined not to pursue, at this time, any public offering. The company had filed the Form S-1, which is the basic SEC registration form for registering the offer and sale of securities under the Securities Act, on Mar.22, 2024. New clinical, pharmacokinetic (PK) and pharmacodynamic (PD) data from the company's phase I study of drug candidate Fadraciclib as monotherapy in patients with advanced solid tumors and lymphoma are slated to be presented on June 1, 2024, at the American Society of Clinical Oncology (ASCO) Annual Meeting.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.